IMAXIMAX
About: Imax Corp is a technology platform for entertainment and events. Through its proprietary software, auditorium architecture, patented intellectual property, and specialized equipment, IMAX offers end-to-end solution to create superior, immersive content experiences for which the IMAX brand is globally renowned. The Company has two reportable segments being Content Solutions and Technology Products and Services. The Company leverages its proprietary technology and engineering in all aspects of its business, which principally consists of the IMAX film remastering and the sale or lease of premium IMAX theater systems.
Employees: 700
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
1,118% more call options, than puts
Call options by funds: $14.3M | Put options by funds: $1.18M
300% more funds holding in top 10
Funds holding in top 10: 1 [Q3] → 4 (+3) [Q4]
76% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 17
28% more capital invested
Capital invested by funds: $938M [Q3] → $1.2B (+$262M) [Q4]
6% more funds holding
Funds holding: 171 [Q3] → 181 (+10) [Q4]
2.41% more ownership
Funds ownership: 86.56% [Q3] → 88.97% (+2.41%) [Q4]
5% less repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 63
Research analyst outlook
7 Wall Street Analysts provided 1 year price targets over the past 3 months
7 analyst ratings
Macquarie Chad Beynon 28% 1-year accuracy 15 / 53 met price target | 32%upside $32 | Outperform Maintained | 25 Apr 2025 |
Wells Fargo Omar Mejias 50% 1-year accuracy 3 / 6 met price target | 23%upside $30 | Overweight Maintained | 24 Apr 2025 |
Barrington Research Patrick Sholl 27% 1-year accuracy 4 / 15 met price target | 32%upside $32 | Outperform Maintained | 24 Apr 2025 |
Rosenblatt Steve Frankel 50% 1-year accuracy 13 / 26 met price target | 44%upside $35 | Buy Maintained | 24 Apr 2025 |
JP Morgan David Karnovsky 48% 1-year accuracy 13 / 27 met price target | 7%upside $26 | Neutral Maintained | 11 Apr 2025 |
Financial journalist opinion
Based on 15 articles about IMAX published over the past 30 days









